Filter
767
Filtered Results: 767
Text search:
World
Health
Organization
WHO,
Regional
Office
for
the
Eastern
Mediterranen
Featured
Recommendations
111
New Publications
155
Language
Document type
No document type
262
Studies & Reports
205
Guidelines
138
Manuals
64
Strategic & Response Plan
41
Training Material
15
Situation Updates
13
Fact sheets
13
Resource Platforms
6
Infographics
6
Brochures
1
App
1
Online Courses
1
Videos
1
Countries / Regions
Global
73
Syria
24
Africa
21
Middle East and North Africa
19
Western and Central Europe
16
Yemen
10
Somalia
9
South–East Asia Region
8
Latin America and the Carribbean
7
Sudan
7
West and Central Africa
6
Eastern Europe
6
Pakistan
6
Nigeria
5
Ethiopia
5
Sierra Leone
4
Afghanistan
4
Jordan
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Lebanon
4
Iraq
4
Liberia
4
Myanmar / Burma
4
Kenya
3
Turkey
3
Ghana
3
Rwanda
3
Iran
3
Asia
3
Saudi Arabia
3
India
3
North Macedonia
2
Nepal
2
Thailand
2
Ukraine
2
China
2
Senegal
2
Philippines
2
Venezuela
2
Western Pacific Region
2
Bangladesh
2
South Africa
2
Uganda
2
Libya
2
Benin
1
Cameroon
1
Albania
1
Morocco
1
Qatar
1
USA
1
Cambodia
1
Croatia
1
Tanzania
1
Congo, Democratic Republic of
1
Tunisia
1
Russia
1
Djibouti
1
Egypt
1
Greece
1
Palestine
1
Georgia
1
South Sudan
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
110
Countries
94
Public Health
83
Women & Child Health
69
Key Resources
55
Capacity Building
25
Pharmacy & Technologies
15
Toolboxes
Mental Health
88
COVID-19
83
Rapid Response
47
Planetary Health
46
TB
42
HIV
39
NTDs
37
Caregiver
33
Refugee
31
Conflict
31
AMR
30
Global Health Education
28
Disability
26
NCDs
24
Pharmacy
19
Ebola & Marburg
12
Polio
11
Cholera
8
Zika
7
Natural Hazards
5
Health Financing Toolbox
5
Specific Hazards
4
Malaria
3
Social Ethics
1
Typhoon
1
Manual for Early Implementation
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
The report reveals that good IPC programmes can reduce health care infections by 70 %. oday, out of every 100 patients in acute-care hospitals, seven patients in high-income countries and 15 patients in low- and middle-income countries will acquire at least one health care-associated infection (HAI)...
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
This document seeks to help health communication professionals working on the topic of immunization more effectively communicate about Events Supposedly Attributed to Vaccination and Immunization (ESAVI) by building trust in National Immunization Programs, understanding risk perceptions related to v...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
A review of proactive risk assessment and risk management practices to ensure the safety of drinking-water
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
Based on information gathered from 118 countries representing every region of the globe, this report provides a picture of WSP uptake worldwide. It presents information on WSP implementati...
People affected by impairments and disabilities associated with TB are even more likely to belong to marginalized segments of society and are more likely to have their human rights unprotected. The challenges faced by people affected by TB include the consequences of impairment and disability associ...
Out of the shadows
Preliminary overview of refugees and migrants self-reported impact of COVID-19
The study surveyed over 30,000 refugees and migrants living in 170 countries. Many of the respondents had fled war or dire economic conditions in their home country only to be faced with the additional challenges posed b...
at the national and acute health care facility level
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
Against this background of nearly 20 years of experience of research, development and
improvement in patient safety, the role of incident and adverse event reporting, as well as the
benefits that derive from it, is still a work in progress.This document has two main purposes:
• to provide an up...
